ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

Panel Angered By Unreasonable Senate Committee Demands, Will Seek Meeting With Hatch On Probe

April 24, 1981

U of Pittsburgh Wins NCI Grant To Include End-of-Life Issues In Med. School Curriculum.

July 6, 2001

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002